To elucidate the molecular mechanisms of TRIM8 in HCC, we conducted Co-immunoprecipitation (Co-IP) and mass spectrometry (MS) to identify potential substrates of TRIM8. The gene discussed is TRIM8; the disease is hepatocellular carcinoma.